BioVie: Jane Street reports 5.2% stake
Rhea-AI Filing Summary
BIOVIE INC. (BIVI) received a Schedule 13G filing reporting that Jane Street Group, LLC and its subsidiaries collectively beneficially own 441,751 shares of Class A Common Stock, representing 5.2% of the class as of August 28, 2026. All of these shares are held with shared voting and dispositive power, with no sole voting or dispositive authority reported.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 441,751 shares
Percent of class owned: 5.2%
Shared voting power: 441,751 shares
+3 more
6 metrics
Beneficial ownership
441,751 shares
Class A Common Stock beneficially owned by Jane Street entities
Percent of class owned
5.2%
Portion of BioVie Inc. Class A Common Stock beneficially owned
Shared voting power
441,751 shares
Shares over which Jane Street entities share voting power
Shared dispositive power
441,751 shares
Shares over which Jane Street entities share dispositive power
Jane Street Capital, LLC ownership
65,435 shares (0.8%)
Portion of BioVie Inc. Class A Common Stock attributed to this subsidiary
Jane Street Global Trading, LLC ownership
376,316 shares (4.5%)
Portion of BioVie Inc. Class A Common Stock attributed to this subsidiary
Key Terms
beneficially owned, shared voting power, shared dispositive power, parent holding company
4 terms
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 441,751.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
parent holding company financial
"If a parent holding company has filed this schedule"
FAQ
When was Jane Street’s 5.2% stake in BIOVIE INC. (BIVI) effective and signed?
The beneficial ownership of 5.2% in BioVie Inc. is reported as of August 28, 2026, and the Schedule 13G was signed by authorized signatory Jeremy Kahn on September 3, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.